JESSICA GORALSKI: Open Payments
NPI 1396467478 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 65 payments from 15 companies in 2025. Trend: 2023 $768 · 2024 $906 · 2025 $1,230
Food & beverage: $1,220Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $316 |
| Phathom Pharmaceuticals, Inc. | 3 | $96 |
| Madrigal Pharmaceuticals | 3 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Ardelyx, Inc. | 3 | $60 |
| Janssen Biotech, Inc. | 3 | $52 |
| GENZYME CORPORATION | 2 | $49 |
| Novo Nordisk Inc | 2 | $44 |
| VIVUS LLC | 2 | $31 |
Products named: ENTYVIO, SKYRIZI, CREON, VOQUEZNA, REZDIFFRA, XIFAXAN, IBSRELA, RINVOQ.
Industry payments across CT — which companies pay providers there.
